H. Kumar et al., An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings, CLIN ENDOCR, 54(6), 2001, pp. 719-723
OBJECTIVE Thyroid cancer is the most common endocrine malignancy but is non
e the less rare. Some aspects of its management remain controversial. Previ
ous audits of patient management in the United Kingdom have revealed defici
encies, especially in communication between specialists. We have audited pa
tient management in a large university-associated teaching hospital, assess
ing points of good practice identified from published guidelines and review
s, and have compared findings in groups of patients managed jointly by spec
ialists with an interest in thyroid cancer (including surgeon, endocrinolog
ist and oncologist) with a group managed by other clinicians outside that s
etting.
DESIGN AND PATIENTS Retrospective case-note review of 205 patients with dif
ferentiated (papillary or follicular) cancer including group A (n = 134; ma
naged in a specialist multi-disciplinary clinic setting) and group B (n = 7
1; managed in other clinic settings). Points of good practice investigated
were adequacy of surgery, surgical complications, prescription and adequacy
of 14 treatment, adequacy of monitoring by measurement of serum thyroglobu
lin and action taken and appropriate administration of ablative radioiodine
.
RESULTS Deficiencies in management of the cohort as a whole were identified
, including inadequate surgery and inadequate TSH suppression in approximat
ely one-fifth of the cases. Monitoring with thyroglobulin measurements and
action when serum thyroglobulin was high were also inadequate in some cases
and ablative radioiodine was not given, despite being indicated in 11.7% o
f the cohort. Inadequate surgery and failure to administer radioiodine were
less common in those managed in a specialist clinic setting than in those
managed in other clinic settings.
CONCLUSIONS The findings highlight the need for locally agreed protocols in
managing relatively rare endocrine disorders such as thyroid cancer and ar
gue in favour of centralization of expertise and patient management in mult
i-disciplinary specialist clinic settings.